ZICKUS-FEIGENHOLTZ-COULSON-HAMOS-DELGADO AND WOJCIK. (RAUSCHENBERGER-RADOGNO) New Act 305 ILCS 5/5-5 from Ch. 23, par. 5-5 Creates the Anti-Obesity and Related Comorbidities Therapy Act and amends the Illinois Public Aid Code. Requires the Department of Public Health, in conjunction with the Department of Public Aid and other agencies, to develop a program to provide obese or at-risk overweight medically indigent patients with services for the treatment and prevention of obesity and its related comorbidities. Provides for coverage of the program services under Medicaid. Effective immediately. FISCAL NOTE (Department of Public Aid) The Department estimates the cost to be between $105 million and $210 million annually. HOUSE AMENDMENT NO. 1. In the Anti-Obesity and Related Comorbidities Therapy Act, deletes gallbladder disease, gastric reflux disease, gout, infertility, osteoarthritis of the hips or knees, and respiratory difficulties from the list of comorbidities in the definition of "at-risk overweight". In the amendatory changes to the Illinois Public Aid Code, provides for Medicaid coverage of services for the treatment and prevention of obesity and its related comorbidities if a patient is otherwise eligible for Medicaid (instead of requiring the Department of Public Aid to provide those services to Medicaid recipients who participate in the program developed by the Department of Public Health under the Anti-Obesity and Related Comorbidities Therapy Act). FISCAL NOTE, H-AM 1 (Department of Public Aid) The Department estimates the cost to be $3,333.08 per person per year ($1.188 per capsulex90 capsules perx12 months+$4.17 dispensing feex12): if 1% of the average Medicaid monthly pop- ulation (14,000 people) qualified for these drugs the estimated cost is $18,663,120 per year. FEB-15-2001 H FILED WITH CLERK FEB-15-2001 H ADDED AS A JOINT SPONSOR ZICKUS FEB-15-2001 H ADDED AS A JOINT SPONSOR HAMOS FEB-15-2001 H FIRST READING FEB-15-2001 H REFERRED TO HOUSE RULES COMMITTEE RULES FEB-21-2001 H ASSIGNED TO COMMITTEE HUMAN SERVS FEB-21-2001 H ADDED AS A JOINT SPONSOR DELGADO MAR-01-2001 H DO PASS/SHORT DEBATE 007-002-000 HHSV MAR-01-2001 H PLACED CALENDAR 2ND READING-SHORT DEBATE MAR-01-2001 H FISCAL NOTE REQUESTED CROSS MAR-01-2001 H CALENDAR ORDER 2ND READING-SHORT DEBATE MAR-14-2001 H FISCAL NOTE FILED MAR-14-2001 H CALENDAR ORDER 2ND READING-SHORT DEBATE MAR-15-2001 H AMENDMENT NO. 01-FEIGENHOLTZ MAR-15-2001 H AMENDMENT REFERRED TO HRUL MAR-15-2001 H CALENDAR ORDER 2ND READING-SHORT DEBATE MAR-15-2001 H ADDED AS A JOINT SPONSOR COULSON MAR-20-2001 H AMENDMENT NO. 01-FEIGENHOLTZ MAR-20-2001 H RECOMMENDS BE ADOPTED HRUL/005-000-000 MAR-20-2001 H SECOND READING-SHORT DEBATE MAR-20-2001 H AMENDMENT NO. 01-FEIGENHOLTZ MAR-20-2001 H ADOPTED MAR-20-2001 H PLCD CAL ORDER 3RD READING-SHORT DEBATE MAR-27-2001 H PRIMARY SPONSOR CHANGED TO ZICKUS MAR-27-2001 H JOINT-SPONSOR CHANGED TO FEIGENHOLTZ MAR-29-2001 H FISCAL NOTE FILED AS AMENDED BY HOUSE AMEND #1 MAR-29-2001 H CALENDAR ORDER 3RD READING-SHORT DEBATE MAR-29-2001 H ADDED AS A CO-SPONSOR WOJCIK MAR-30-2001 H THIRD READING/SHORT DEBATE/PASSED 106-008-002 APR-02-2001 S ARRIVE IN SENATE APR-02-2001 S PLACED CALENDAR ORDER OF FIRST READING 01-04-03 APR-04-2001 S CHIEF SPONSOR RADOGNO APR-04-2001 S FIRST READING APR-04-2001 S REFERRED TO SENATE RULES COMMITTEE RULES APR-19-2001 S SPONSOR REMOVED RADOGNO APR-19-2001 S ALTERNATE CHIEF SPONSOR CHANGED TO RAUSCHENBERGER APR-19-2001 S ADDED AS A CHIEF CO-SPONSOR RADOGNO APR-25-2001 S ADDED AS A CO-SPONSOR OBAMA JAN-07-2003 H SESSION SINE DIE END OF INQUIRY Full Text Bill Summary